tiprankstipranks
Trending News
More News >
Fielmann AG (DE:FIE)
XETRA:FIE
Advertisement

Fielmann (FIE) AI Stock Analysis

Compare
12 Followers

Top Page

DE:FIE

Fielmann

(XETRA:FIE)

Rating:72Outperform
Price Target:
€61.00
▲(11.72% Upside)
Fielmann's strong financial performance is the primary driver of its overall score, supported by consistent revenue and profit growth, efficient cost management, and a stable balance sheet. Technical analysis indicates a lack of strong momentum, with the stock trading below key moving averages. Valuation metrics suggest the stock may be overvalued, but the dividend yield offers some compensation. The absence of recent earnings call insights and corporate events limits additional context.

Fielmann (FIE) vs. iShares MSCI Germany ETF (EWG)

Fielmann Business Overview & Revenue Model

Company DescriptionFielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses and accessories, and various merchandise, as well as hearing aids and accessories. As of December 31, 2021, it operated 693 stores, including 610 in Germany, 45 in Switzerland, 38 Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and 15 in the rest of Europe. The company also 78 smaller locations in Eastern Europe. It also offers its products through online stores. The company was founded in 1972 and is headquartered in Hamburg, Germany. Fielmann Aktiengesellschaft is a subsidiary of Korva SE.
How the Company Makes MoneyFielmann generates revenue primarily through the sale of eyewear products, including prescription glasses, sunglasses, and contact lenses. The company operates a retail model, where customers can purchase products directly from their stores or online. Additionally, Fielmann offers eye examinations and optical services, which also contribute to its revenue. The company benefits from a strong brand reputation and customer loyalty, leading to repeat business. Key revenue streams include direct product sales, service fees from eye exams, and partnerships with various lens and frame manufacturers, which may provide discounts or incentives for Fielmann to sell their products. The company's extensive store network and e-commerce platform further enhance its reach and sales potential.

Fielmann Financial Statement Overview

Summary
Fielmann exhibits a solid financial performance with strong revenue and profit growth, efficient cost management, and a stable balance sheet. Despite a rise in leverage, profitability and cash flow generation have improved. The company's reinvestment in capital expenditures indicates a commitment to growth, though it requires careful management of cash reserves.
Income Statement
85
Very Positive
Fielmann has demonstrated consistent revenue growth over the years, with a notable increase from 2019 to 2024. The gross profit margin is strong, consistently above 75%, indicating efficient cost management. The net profit margin and EBIT margin have shown positive trends, reflecting profitability improvements. However, the EBITDA margin and net income growth have been more volatile, suggesting some fluctuations in operational efficiency.
Balance Sheet
78
Positive
The balance sheet reveals a healthy equity position, with the equity ratio improving over time. The debt-to-equity ratio has increased, signaling higher leverage, but remains within manageable levels. Return on Equity (ROE) has shown a positive trajectory, indicating effective use of equity to generate profits. Despite the increased debt, the overall stability of the balance sheet is maintained.
Cash Flow
82
Very Positive
Fielmann's cash flow statements show robust operating cash flow, consistently covering capital expenditures. The free cash flow has grown steadily, enhancing liquidity. The operating cash flow to net income ratio suggests strong cash generation relative to profitability. However, a notable capital expenditure in recent years indicates significant reinvestment in the business, which could impact immediate cash reserves.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.72B2.26B1.97B1.76B1.68B1.43B
Gross Profit1.39B1.81B1.57B1.38B1.34B1.15B
EBITDA318.86M475.73M403.80M346.99M389.78M328.70M
Net Income122.63M152.11M127.64M103.66M136.85M116.41M
Balance Sheet
Total Assets0.002.37B1.99B1.77B1.74B1.67B
Cash, Cash Equivalents and Short-Term Investments101.68M101.68M81.83M149.87M235.54M221.24M
Total Debt0.00873.85M592.15M505.66M458.26M425.72M
Total Liabilities-913.14M1.46B1.06B909.10M863.09M832.86M
Stockholders Equity913.14M899.13M867.65M804.22M819.83M779.20M
Cash Flow
Free Cash Flow0.00327.41M196.00M182.69M260.15M188.40M
Operating Cash Flow0.00410.09M282.79M268.08M346.69M278.47M
Investing Cash Flow0.00-331.17M-143.25M-159.85M-74.85M-219.67M
Financing Cash Flow0.00-44.27M-112.57M-232.33M-201.22M-85.42M

Fielmann Technical Analysis

Technical Analysis Sentiment
Positive
Last Price54.60
Price Trends
50DMA
55.80
Negative
100DMA
53.95
Positive
200DMA
47.57
Positive
Market Momentum
MACD
-0.34
Positive
RSI
49.77
Neutral
STOCH
62.09
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:FIE, the sentiment is Positive. The current price of 54.6 is below the 20-day moving average (MA) of 55.02, below the 50-day MA of 55.80, and above the 200-day MA of 47.57, indicating a neutral trend. The MACD of -0.34 indicates Positive momentum. The RSI at 49.77 is Neutral, neither overbought nor oversold. The STOCH value of 62.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:FIE.

Fielmann Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
€4.59B27.0917.47%2.09%
56
Neutral
$13.44B18.2610.03%0.94%7.13%-12.93%
€3.70B23.387.48%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:FIE
Fielmann
54.60
10.09
22.67%
GB:0DHC
Carl Zeiss Meditec
41.02
-16.98
-29.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2025